Petefészekrák: vizsgálatok itt: India
7 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleTorvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer
- Where
- Ansārinagar, Bhubaneswar, Hyderabad, Mumbai, Nagpur, Nashik, New Delhi, Pune, Thiruvananthapuram
- Életkor
- 18 év and over
- People
- 950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07851025 · EU 2026-526895-22-00 - 3. fázisTaking peopleStudy of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Where
- Ahmedabad, Delhi, Kolkata, Mumbai, Nagpur, Nashik, Pune, Vadodara, Varanasi, Visakhapatnam
- Életkor
- 18 év and over
- People
- 582 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06819007 · EU 2024-516982-35-00 - 3. fázisCsak meghívásosSafety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
- Where
- Bangalore, Bengaluru, Erode, Mysore, Nagpur, Pune, Surat, Varanasi
- Életkor
- 18 év to 51 év
- People
- 250 worldwide
- Run by
- Tolmar Inc.
See details and how to joinNCT05645536 - 3. fázisTaking peopleTorvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
- Where
- Ahmedabad, Bangalore, Gūrgaon, Kottayam, Madurai, Nashik, New Delhi, Vadodara
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07816666 · EU 2026-526776-23-00 - 3. fázisTaking peopleActive Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Where
- Mumbai
- People
- 1780 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03067181 - 3. fázisTaking peopleAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- Bhubaneswar, Chennai, Delhi, Dhanvantari Nagar, Kolkata, Nagpur, Nashik, Surat, Tiruchirappalli
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00 - No phaseTaking peopleAn Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- Where
- Mumbai
- Életkor
- 18 év to 70 év
- People
- 400
- Run by
- Tata Memorial Centre
See details and how to joinNCT02754115